Dagens industri: Zinzino's Revenue Jumps 48% in Q3 2025

According to Dagens Industri, Zinzino AB reported a substantial increase in revenue for the third quarter of 2025. Total revenue reached 786.7 million SEK, a 48% increase compared to 532.8 million SEK in the same period of the previous year. This growth was primarily fueled by a 54% increase in sales market revenue, contributing 777.3 million SEK to the quarterly total. September 2025 also demonstrated strong performance, with revenues increasing by 50% year-over-year to 277.2 million SEK. Sales markets generated 273.5 million SEK, representing a 53% increase compared to September 2024. Conversely, external sales from Faun Pharma declined to 3.7 million SEK, a decrease from 5.8 million SEK in the prior year. For the first nine months of 2025, Zinzino's cumulative sales rose by 54% to 2,304.9 million SEK, up from 1,494.3 million SEK during the same period in 2024. Regionally, the Asia-Pacific market exhibited the most significant growth in Q3, with revenues increasing by 186% to 63.7 million SEK. North America followed, with a 147% increase to 129.8 million SEK. Central Europe, a key market for Zinzino, experienced a 75% growth, reaching 242.8 million SEK. Other regions posting positive Q3 growth included Africa (+46%), South & West Europe (+32%), the Baltics (+31%), the Nordic region (+10%), and Eastern Europe (+2%). Throughout the January-to-September period, Asia-Pacific and North America continued to lead growth, with rates of 348% and 185%, respectively. Eastern Europe was the only region to experience a slight year-to-date sales decline of 1%.